{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:23:08Z","timestamp":1780507388515,"version":"3.54.1"},"reference-count":31,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01CA261937"],"award-info":[{"award-number":["R01CA261937"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["I01BX005917"],"award-info":[{"award-number":["I01BX005917"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["I01CX002210"],"award-info":[{"award-number":["I01CX002210"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["IK6BX006041"],"award-info":[{"award-number":["IK6BX006041"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","award":["R01CA261937"],"award-info":[{"award-number":["R01CA261937"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01BX005917"],"award-info":[{"award-number":["I01BX005917"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01CX002210"],"award-info":[{"award-number":["I01CX002210"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","award":["IK6BX006041"],"award-info":[{"award-number":["IK6BX006041"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The polo-like kinase (PLK) family of serine\/threonine kinases contains five members (PLK1\u20135). Most PLKs are involved in cell cycle regulation and DNA damage response. However, PLK5 is different as it lacks a functional kinase domain and is not involved in cell cycle control. PLK5 remains the least-studied family member, and its role in oncogenesis remains enigmatic. Here, we identified tissues with high PLK5 expression by leveraging the Protein Atlas and GTEx databases with relevant literature and selected ovarian, lung, testis, endometrium, cervix, and fallopian tube tissues as candidates for further investigation. Subsequently, we performed immunohistochemical staining for PLK5 on multiple tissue microarrays followed by Vectra scanning and quantitative inForm analysis. This revealed consistently downregulated PLK5 expression in these cancers compared to normal tissues. To validate and extend our findings, we performed pan-cancer analysis of PLK5 expression using public RNAseq databases (TCGA and GTEx). We found PLK5 is downregulated in 18 cancer types, including our selected candidates. Interestingly, we also observed PLK5 expression remains consistently low in later stages of cancer, suggesting PLK5 may have a greater role in tumor initiation than cancer progression. Overall, our study demonstrates PLK5 downregulation in multiple cancers, highlighting its role as a tumor suppressor.<\/jats:p>","DOI":"10.3390\/cancers15225457","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T09:23:43Z","timestamp":1700213023000},"page":"5457","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Potential Tumor Suppressor Role of Polo-like Kinase 5 in Cancer"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6946-8256","authenticated-orcid":false,"given":"Shengqin","family":"Su","sequence":"first","affiliation":[{"name":"Department of Dermatology, University of Wisconsin, Madison, WI 53705, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5254-1840","authenticated-orcid":false,"given":"Mary Ann","family":"Ndiaye","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Wisconsin, Madison, WI 53705, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glorimar","family":"Guzm\u00e1n-P\u00e9rez","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Wisconsin, Madison, WI 53705, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca Michael","family":"Baus","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI 53705, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI 53705, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8205-6432","authenticated-orcid":false,"given":"Manish Suresh","family":"Patankar","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Wisconsin, Madison, WI 53792, USA"},{"name":"William S. Middleton VA Medical Center, Madison, WI 53705, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4239-9887","authenticated-orcid":false,"given":"Nihal","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Wisconsin, Madison, WI 53705, USA"},{"name":"William S. Middleton VA Medical Center, Madison, WI 53705, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1158\/0008-5472.CAN-13-2197","article-title":"The role of polo-like kinase 1 in carcinogenesis: Cause or consequence?","volume":"73","author":"Cholewa","year":"2013","journal-title":"Cancer Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1158\/1535-7163.MCT-20-0741","article-title":"Role of Polo-Like Kinase 4 (PLK4) in Epithelial Cancers and Recent Progress in its Small Molecule Targeting for Cancer Management","volume":"20","author":"Garvey","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1158\/1535-7163.MCT-15-0897","article-title":"Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics","volume":"15","author":"Gutteridge","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"101332","DOI":"10.1016\/j.tranon.2021.101332","article-title":"PLK1 inhibition-based combination therapies for cancer management","volume":"16","author":"Su","year":"2022","journal-title":"Transl. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrd3184","article-title":"Multifaceted polo-like kinases: Drug targets and antitargets for cancer therapy","volume":"9","author":"Strebhardt","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.onc.1208272","article-title":"Polo-like kinases (Plks) and cancer","volume":"24","author":"Takai","year":"2005","journal-title":"Oncogene"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1038\/onc.2014.451","article-title":"Understanding the Polo Kinase machine","volume":"34","author":"Archambault","year":"2015","journal-title":"Oncogene"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.12717\/DR.2014.18.1.065","article-title":"Polo-like kinases (plks), a key regulator of cell cycle and new potential target for cancer therapy","volume":"18","author":"Lee","year":"2014","journal-title":"Dev. Reprod."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/sj.onc.1208219","article-title":"Differential regulation of polo-like kinase 1, 2, 3, and 4 gene expression in mammalian cells and tissues","volume":"24","author":"Winkles","year":"2005","journal-title":"Oncogene"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.tranon.2015.03.010","article-title":"Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer Treatment","volume":"8","author":"Liu","year":"2015","journal-title":"Transl. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"11707","DOI":"10.1073\/pnas.0306880101","article-title":"The mouse kinome: Discovery and comparative genomics of all mouse protein kinases","volume":"101","author":"Caenepeel","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1126\/science.1075762","article-title":"The protein kinase complement of the human genome","volume":"298","author":"Manning","year":"2002","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1128\/MCB.00607-10","article-title":"Plk5, a polo box domain-only protein with specific roles in neuron differentiation and glioblastoma suppression","volume":"31","author":"Escobar","year":"2011","journal-title":"Mol. Cell Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1093\/nar\/gkq011","article-title":"The novel mouse Polo-like kinase 5 responds to DNA damage and localizes in the nucleolus","volume":"38","author":"Andrysik","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.4161\/cc.10.14.16494","article-title":"From Plk1 to Plk5: Functional evolution of polo-like kinases","volume":"10","author":"Manning","year":"2011","journal-title":"Cell Cycle"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"964044","DOI":"10.3389\/fsurg.2022.964044","article-title":"Polo-like kinase (PLK) 5, a new member of the PLK family, serves as a biomarker to indicate anabatic tumor burden and poor prognosis for resectable non-small cell lung cancer","volume":"9","author":"Wang","year":"2022","journal-title":"Front. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1007\/s00432-020-03288-6","article-title":"Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer","volume":"146","author":"Zeng","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cancergen.2022.09.007","article-title":"Comprehensive analysis of PLKs expression and prognosis in breast cancer","volume":"268\u2013269","author":"Jiawei","year":"2022","journal-title":"Cancer Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00381-017-3366-5","article-title":"PLK1-associated microRNAs are correlated with pediatric medulloblastoma prognosis","volume":"33","author":"Pezuk","year":"2017","journal-title":"Childs Nerv. Syst."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"16172","DOI":"10.18632\/oncotarget.7473","article-title":"Genetic mutations associated with metastatic clear cell renal cell carcinoma","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Auguste, A., Blanc-Durand, F., Deloger, M., Le Formal, A., Bareja, R., Wilkes, D.C., Richon, C., Brunn, B., Caron, O., and Devouassoux-Shisheboran, M. (2020). Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis. Cells, 9.","DOI":"10.3390\/cells9061496"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"D1334","DOI":"10.1093\/nar\/gkab970","article-title":"OncoDB: An interactive online database for analysis of gene expression and viral infection in cancer","volume":"50","author":"Tang","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: An enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"6352","DOI":"10.1126\/science.aan2507","article-title":"A pathology atlas of the human cancer transcriptome","volume":"357","author":"Uhlen","year":"2017","journal-title":"Science"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"6340","DOI":"10.1126\/science.aal3321","article-title":"A subcellular map of the human proteome","volume":"356","author":"Thul","year":"2017","journal-title":"Science"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1074\/mcp.M500279-MCP200","article-title":"A human protein atlas for normal and cancer tissues based on antibody proteomics","volume":"4","author":"Uhlen","year":"2005","journal-title":"Mol. Cell Proteomics"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"D752","DOI":"10.1093\/nar\/gky1099","article-title":"Update of the FANTOM web resource: Expansion to provide additional transcriptome atlases","volume":"47","author":"Lizio","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Lizio, M., Harshbarger, J., Shimoji, H., Severin, J., Kasukawa, T., Sahin, S., Abugessaisa, I., Fukuda, S., Hori, F., and Ishikawa-Kato, S. (2015). Gateways to the FANTOM5 promoter level mammalian expression atlas. Genome Biol., 16.","DOI":"10.1186\/s13059-014-0560-6"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/22\/5457\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:24:48Z","timestamp":1760131488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/22\/5457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,17]]},"references-count":31,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["cancers15225457"],"URL":"https:\/\/doi.org\/10.3390\/cancers15225457","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,17]]}}}